RxDoctor Payments DataLook up a doctor →

George Carr, MD

Family Medicine · Jefferson City, MONPI 1528032661

Payments from drug & device makers

$2,067,136in general payments, 2019–2025

Across 2,418 payments — averaging $854.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alnylam Pharmaceuticals Inc.$650K
  • Novartis$540K
  • Astrazeneca UK Limited$456K
  • Johnson & Johnson$184K
  • AstraZeneca$108K
  • GSK$39K
  • plus $89K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alnylam Pharmaceuticals Inc.1,282$650,304
Novartis9$540,443
Astrazeneca UK Limited3$456,027
Johnson & Johnson40$183,503
AstraZeneca60$108,185
GSK38$39,138
Pfizer142$29,635
Boehringer Ingelheim12$18,255
Boehringer Ingelheim Pharma GmbH & Co.kg4$16,692
Sunovion Pharmaceuticals Inc.50$7,293
Myovant Sciences Inc.1$3,117
AbbVie(2 entities)195$2,833
Medtronic30$2,074
Novo Nordisk89$1,216
Boehringer Ingelheim International GmbH12$954
Amgen50$748
Lilly USA, LLC44$646
Bayer41$617
Abbott21$591
Merck26$368
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC30$366
Amarin Pharma, Inc.22$307
Otsuka America Pharmaceutical, Inc.12$224
Dexcom, Inc.9$219
Takeda Pharmaceuticals U.S.A., Inc.15$218
Lundbeck LLC8$196
Biohaven Pharmaceutical Holding Company Ltd.15$194
Jazz Pharmaceuticals Inc.10$170
Supernus Pharmaceuticals, Inc.12$167
Teva Pharmaceuticals USA, Inc.10$161
Astellas Pharma US Inc6$157
Phathom Pharmaceuticals, Inc.10$150
Biohaven Pharmaceuticals, Inc.10$145
Straumann USA LLC1$141
Averitas Pharma Inc.7$141
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)7$112
Esperion Therapeutics, Inc.6$102
Mylan Specialty L.p.6$92
SK Life Science, Inc.4$84
Axsome Therapeutics, Inc.4$76
Edwards Lifesciences3$74
Kowa Pharmaceuticals America, Inc.5$72
Tolmar, Inc.3$68
Biogen4$59
Melinta Therapeutics, LLC4$59
E.r. Squibb & Sons, L.L.C.4$58
Verona Pharma, Inc.3$55
Exact Sciences3$47
Arbor Pharmaceuticals, Inc.3$46
Sumitomo Pharma America, Inc.3$46
Impel Pharmaceuticals Inc.3$45
Viatris Specialty LLC2$44
Alkermes, Inc.2$39
Ironwood Pharmaceuticals, Inc2$36
Neurocrine Biosciences, Inc.2$33
Radius Health, Inc.2$31
Ardelyx, Inc.2$30
Daiichi Sankyo Inc.2$27
Sanofi Pasteur Inc.2$26
Antares Pharma, Inc.1$20

How this compares

$2,067,136 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri →

Medicare billing

Part B allowed, 2024
$301,982
Medicare patients
363
Services billed
11,179

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Jefferson City

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →